Literature DB >> 16231399

First prenatal molecular diagnosis in a family with holocarboxylase synthetase deficiency.

Sabrina Malvagia1, Amelia Morrone, Elisabetta Pasquini, Silvia Funghini, Giancarlo la Marca, Enrico Zammarchi, Maria Alice Donati.   

Abstract

OBJECTIVES: We report on the first prenatal molecular diagnosis of holocarboxylase synthetase (HLCS) deficiency in the fourth pregnancy of an at-risk family. This disorder is a rare autosomal recessive inborn error of metabolism, leading to a multiple carboxylase defect (MCD). HLCSD diagnosis was performed postmortem in the proband on DNA from autoptic biological material. Molecular analysis of the proband's entire HLCS gene by direct sequencing identified the R508W amino acid change, at the homozygous status.
METHODS: Fetal DNA was isolated from chorionic villus sampling at 11 weeks of gestation. Direct sequencing of exon 6 of the fetal HLCS gene was performed.
RESULTS: The R508W mutation was identified in the fetal DNA at the homozygous level. The genetic lesion was confirmed on abortive tissue.
CONCLUSION: Molecular diagnosis has several advantages over enzymatic activity assay of carboxylases in chorionic villi or amniocytes. It can be performed earlier, is faster, and the response time is shorter. Copyright 2005 John Wiley & Sons, Ltd

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16231399     DOI: 10.1002/pd.1291

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

Review 1.  Prenatal pharmacotherapy for fetal anomalies: a 2011 update.

Authors:  Lisa Hui; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2011-06-03       Impact factor: 3.050

2.  Clinical, biochemical, and genetic analysis of a Chinese Han pedigree with holocarboxylase synthetase deficiency: a case report.

Authors:  Zhenzhu Zheng; Gaopin Yuan; Minyan Zheng; Yiming Lin; Faming Zheng; Mengyi Jiang; Lin Zhu; Qingliu Fu
Journal:  BMC Med Genet       Date:  2020-07-29       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.